Press releases
- Press releases
- Browse
Press releases
Research into neurodegenerative disease at the Institute of Psychiatry has resulted in the development of a series of biomarkers, or tests, for Alzheimer’s disease. More
Astex Technology, announced that it has received the second milestone payment from AstraZeneca as part of its collaboration to identify novel drugs against a key protein target implicated in Alzheimer's Disease. More
LAY LINE GENOMICS (LLG) grants a non-exclusive license to LUNDBECK for its AD11 transgenic anti-NGF mouse More
Consistent data in three Phase IIa clinical trials in depression patients with melancholic characteristics More
Lay Line Genomics licenses AD11 mouse model for Alzheimer's disease to Johnson & Johnson Pharmaceutical Research & Development. More
Lay Line Genomics (LLG) announces today that the company has entered into a collaborative partnership with Roche More
BioXell S.p.A. and Lay Line Genomics S.p.A. (LLG) today announced an exclusive, worldwide license agreement for the development of MNAC13, a novel humanized monoclonal antibody that binds to TrkA receptors, blocking the action of Nerve Growth Factor More
Related Reports
Market Research Reports provided by reports.iptechex.com
Sep 2011 - 97 pages - $3,500
Sep 2010 - 137 pages - $3,835
Mar 2011 - 6 pages - $500
Mar 2011 - 5 pages - $500
Feb 2011 - 209 pages - $3,500
Aug 2008 - 62 pages - $1,040
Jan 2011 - 6 pages - $500
Nov 2010 - 18 pages - $2,350
Feb 2011 - 75 pages - $1,000
Jun 2011 - 132 pages - $2,350
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us